Results 151 to 160 of about 279,790 (190)

CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. [PDF]

Cancer Metastasis Rev
Wells J, Gupta A.
europepmc   +1 more source

Rhabdoid tumors as a novel target for PSMA-directed CAR T cell therapy. [PDF]

Mol Ther Oncol
Mitra A, Zhou T, Wu J, Nguyen T, Yu C, Barua A, Huang L, Jiang X, Venkatramani R, Jin MM, He B, Feng Q.   +11 more
europepmc   +1 more source

Role of Frailty in Assessing Eligibility for CAR T-Cell Therapy in Haematology. [PDF]

Eur J Haematol
Clesham J, McGrory J, Bannon A, Cox D, Dowling M.   +4 more
europepmc   +1 more source

CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma. [PDF]

Hematology Am Soc Hematol Educ Program
Dima D, Banerjee R, Hansen DK.
europepmc   +1 more source

Engineering BiTE-inspired IPSC-exosomes to potentiate CAR-T cell therapy against lung cancer. [PDF]

J Nanobiotechnology
Wang R, Fu G, Dou H, Hu M, Li Z, Gan J, He J, Li X, Zhang G, Li X, Zhu T, Cao Q.   +11 more
europepmc   +1 more source

From technological iteration to clinical breakthrough: advances of CAR-T cell therapy in autoimmune diseases. [PDF]

Ann Med
Yu B, Xu J, Cui Y.
europepmc   +1 more source

Emapalumab in pediatric patients with high-grade cytokine release syndrome associated with CAR T-cell therapy. [PDF]

Front Immunol
Zhang J, Shi W, Yang J, Qian J, Su M, An K, Wang T, Jia R, Fei C, Tang Y, Li B.   +10 more
europepmc   +1 more source

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma. [PDF]

Blood Adv
Yoon SE, Kang W, Cho J, Cho HJ, Chalita M, Oh HS, Hyun DW, Han S, Kim H, Sung H, Lee JY, Park B, Ryu KJ, Kim HY, Cho D, Kim WS, Kim SJ.   +16 more
europepmc   +1 more source

CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors. [PDF]

Front Immunol
Shen S, Ruan Z, Jiang B, Qiu W, Zhang F, Shu R.   +5 more
europepmc   +1 more source